Korea Arlico Pharm Co., Ltd.

Korea Arlico Pharm overcame numerous obstacles over a 30-year journey to become one of Korea's 50 major pharmaceutical companies, listing on KOSDAQ in 2018. Its nationwide sales networks and sales power drove consistent annual sales growth averaging up to 23% from 2015 to 2022, operating as a CMO specialized in generic pharmaceuticals at a PIC/S GMP-certified facility.